Drug-induced immune hemolytic anemia: the last 30 years of changes
By:
Paid access
|Nov 2019References
- Garratty G. Drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1985; 2:1–8.
- Harris JW. Studies on the mechanism of a drug-induced hemolytic anemia. J Lab Clin Med 1956;47:760–75.
- Carstairs KC, Breckenridge A, Dollery CT, Worlledge SM. Incidence of a positive direct Coombs test in patients on α-methyldopa. Lancet 1966;2:133–5.
- Worlledge SM, Carstairs KC, Dacie JV. Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy. Lancet 1966;2:135–9.
- Gralnick HR, Wright LD Jr, McGinniss MH. Coombs’ positive reactions associated with sodium cephalothin therapy. JAMA 1967;199:135–6.
- Molthan L, Reidenberg MM, Eichman MF. Positive direct Coombs tests due to cephalothin. N Eng J Med 1967;277: 123–5.
- Spath P, Garratty G, Petz L. Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin administration. J Immunol 1971;107: 860–9.
- Petz LD, Garratty G. Acquired immune hemolytic anemias. 1st ed. New York: Churchill Livingstone, 1980.
- Kirtland HH, Mohler DN, Horwitz DA. Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia. N Engl J Med 1980;302: 825–32.
- Miescher P, Cooper N. The fixation of soluble antigen-antibody-complexes upon thrombocytes. Vox Sang 1960;5:138–42.
- Shulman NR. A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in autoimmunity. Ann Intern Med 1964;60:506–21.
- Christie DJ, Mullen PC, Aster RH. Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 1985;75: 310–14.
- Smith ME, Reid DM, Jones CE, Jordan JV, Kautz CA, Shulman NR. Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent. J Clin Invest 1987;79:912–17.
- Jordan JV, Smith ME, Reid DM, Jones CE, Kautz CA, Shulman NR. A tolmetin-dependent antibody causing severe intravascular hemolysis binds to erythrocyte band 3 and requires only the F(ab′)2 domain to react (abstract). Blood 1985;66(Suppl):104a.
- Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 2009;7:911–18.
- Habibi B, Bretagne Y. Blood group antigens may be the receptors for specific drug-antibody complexes reacting with red blood cells (in French). C R Seances Acad Sci III 1983;296:693–6.
- Johnson ST, Weitekamp LA, Wilkins JL, Heim ED, MacDonald JD, Barylak EJ. Diclofenac-dependent antibody with relative e specificity causing hemolytic anemia and emphasizing the need for metabolite testing (abstract). Transfusion 1993;33(Suppl):63S.
- Shirey RS, Bartholomew J, Bell W, Pollack B, Kickler TS, Ness PM. Characterization of antibody and selection of alternative drug therapy in hydrochlorothiazide-induced immune hemolytic anemia. Transfusion 1988;28:70–2.
- Johnson ST, Fueger JT, Gottschall JL, Aster RH. Ibuprofen-dependent antibody with Rh specificity reacting with untreated red cells in the presence of drug (abstract). Transfusion 1996; 36(Suppl):54S.
- Salama A, Mueller-Eckhardt C. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine. Blood 1986;68:1285–8.
- Johnson ST, Weitekamp LA, Sauer DE, Fueger JT, Aster RH. Piperacillin-dependent antibody with relative e specificity reacting with drug treated red cells and untreated red cells in the presence of drug (abstract). Transfusion 1994;34(Suppl):70S.
- Osbourne SE, Johnson ST, Weitekamp LA, Curtis BR, Aster RH. Enhanced detection of drug-dependent antibodies reacting with untreated red blood cells in the presence of drug (abstract). Transfusion 1994;34(Suppl):20S.
- Ahrens N, Genth R, Salama A. Belated diagnosis in three patients with rifampicin-induced immune haemolytic anaemia. Br J Haematol 2002;117:441–3.
- Letona JML, Barbolla L, Frieyro E, Bouza E, Gilsanz F, Fernández MN. Immune haemolytic anaemia and renal failure induced by streptomycin. Br J Haematol 1977;35:561–71.
- DeCoteau J, Reis MD, Pinkerton PH, Ward J, Coovadia AS. Positive antiglobulin test in association with sulindac: involvement of the Rh factor. Vox Sang 1993;64:179–83.
- Colluccio E, Villa MA, Villa E, et al. Immune hemolytic anemia associated with teicoplanin. Transfusion 2004;44:73–6.
- Weitekamp LA, Johnson ST, Fueger JT, Clark JR, Aster RH. A fatal case of tolmetin-induced hemolytic anemia with relative e specificity (abstract). Transfusion 1991;31(Suppl):52S.
- Duran-Suarez JR, Martin-Vega C, Argelagues E, Massuet L, Ribera A, Triginer J. Red cell I antigen as immune complex receptor in drug-induced hemolytic anemias. Vox Sang 1981;41:313–15.
- Sandvei P, Nordhagen R, Michaelsen TE, Wolthuis K. Fluorouracil (5-FU) induced acute immune haemolytic anaemia. Br J Haematol 1987;65:357–9.
- Nordhagen R, Vik H, Wolthuis K, Bøhn HP, Urdahl P, Michaelsen TE. Immune-mediated hemolysis associated with the administration of a radiographic contrast medium. Transfusion 1991;31:843–6.
- Salama A, Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood 1987;69:1006–10.
- Habibi B, Basty R, Chodez S, Prunat A. Thiopental-related immune hemolytic anemia and renal failure. Specific involvement of red-cell antigen I. N Engl J Med 1985;312: 353–5.
- Arndt PA, Revilla J, Leger RM, Garratty G. Studies on specificity of selected drug-dependent antibodies (abstract). Transfusion 2013;53(Suppl):17A.
- Pham B-N, Gien D, Bensaad F, et al. Antibodies to co-trimoxazole (trimethoprim and/or sulfamethoxazole) related to the presence of the drug in a commercial low-ionic-strength solution. Transfusion 2012;52:844–8.
- Sosler SD, Behzad O, Garratty G, Lee CL, Postoway N, Khomo O. Acute hemolytic anemia associated with a chlorpropamide-induced apparent auto anti-Jka. Transfusion 1984;24:206–9.
- Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004.
- Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 2010;24:143–50.
- Ackroyd JF. Allergic purpura, including purpura due to foods, drugs and infections. Am J Med 1953;14:605–32.
- Mueller-Eckhardt C, Salama A. Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev 1990;4:69–77.
- Shulman NR, Reid DM. Mechanisms of drug-induced immunologically mediated cytopenias. Transfus Med Rev 1993;7:215–29.
- Aster RH. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin Hematol 1999;36(Suppl 1): 2–6.
- Habibi B. Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias. Br J Haematol 1985;61:139–43.
- Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodies. Blood 2006;108: 922–7.
- Garratty G. Immune cytopenia associated with antibiotics. Transfus Med Rev 1993;7:255–67.
- Salama A, Göttsche B, Schleiffer T, Mueller-Eckhardt C. ‘Immune complex’ mediated intravascular hemolysis due to IgM cephalosporin-dependent antibody. Transfusion 1987;27: 460–3.
- Garratty G, Postoway N, Schwellenbach J, McMahill PC. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion 1991;31:176–9.
- Leger RM, Arndt PA, Garratty G. How we investigate drug-induced immune hemolytic anemia. Immunohematology 2014;30:85–94.
- Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol 2005;42:137–44.
- Johnson ST, Fueger JT, Gottschall JL. One center’s experience: the serology and drugs associated with drug-induced immune hemolytic anemia—a new paradigm. Transfusion 2007;47: 697–702.
- Quillen K, Lane C, Hu E, Pelton S, Bateman S. Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection. Pediatr Infect Dis J 2008;27:357–8.
- Arndt PA, Leger RM, Garratty G. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia. Transfusion 2012;52:602–12.
- Meyer O, Hackstein H, Hoppe B, Göbel FJ, Bein G, Salama A. Fatal immune haemolysis due to a degradation product of ceftriaxone. Br J Haematol 1999;105:1084–5.
- Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 2000;26:1390–4.
- Kim S, Song KS, Kim HO, Lee HM. Ceftriaxone induced immune hemolytic anemia: detection of drug-dependent antibody by ex-vivo antigen in urine. Yonsei Med J 2002;43: 391–4.
- Arndt PA. Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone—a case study approach. Immunohematology 2002;18:27–32.
- Arndt PA, Leger RM, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 1999;39:1239–46.
- Garratty G, Leger RM, Arndt PA. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures. Am J Obstet Gynecol 1999;181:103–4.
- Perkins J. Fatal drug-induced immune hemolytic anemia due to cefotetan: a case study. Asian J Transfus Sci 2008;2:20–3.
- Arndt P, Garratty G. Is severe immune hemolytic anemia, following a single dose of cefotetan, associated with the presence of “naturally-occurring” anti-cefotetan (abstract)? Transfusion 2001;41(Suppl):24S.
- Davenport RD, Judd WJ, Dake LR. Persistence of cefotetan on red blood cells. Transfusion 2004;44:849–52.
- Viraraghavan R, Chakravarty AG, Soreth J. Cefotetan-induced haemolytic anaemia. A review of 85 cases. Adverse Drug React Toxicol Rev 2002;21:101–7.
- Arndt PA, Garratty G. Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other cephalosporins and penicillin. Am J Clin Pathol 2002;118:256–62.
- Arndt PA, Leger RM, Garratty G. Reactivity of “last wash” elution controls in investigation of cefotetan antibodies (abstract). Transfusion 1999;39(Suppl):47S.
- Williams ME, Thomas D, Harman CP, Mintz PD, Donowitz GR. Positive direct antiglobulin tests due to clavulanic acid. Antimicrob Agents Chemother 1985;27:125–7.
- Lutz P, Dzik W. Very high incidence of a positive direct antiglobulin test (+ DAT) in patients receiving Unasyn® (abstract). Transfusion 1992;32(Suppl):23S.
- Garratty G, Arndt PA. Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells. Br J Haematol 1998;100:777–83.
- Arndt P, Garratty G. Can nonspecific protein coating of RBCs lead to increased RBC destruction? Drug-treated RBCs with positive antiglobulin tests due to nonspecific uptake give positive monocyte monolayer assays (abstract). Transfusion 2000;40(Suppl):29S.
- Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004;44:1273–81.
- Arndt PA, Leger RM, Garratty G. Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells. Vox Sang 2003;85:53.
- Broadberry RE, Farren TW, Bevin SV, et al. Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient’s red cells. Transfus Med 2004;14:53–7.
- Arndt PA, Garratty G, Hill J, Kasper M, Chandrasekaran V. Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the ‘immune complex’ method. Vox Sang 2002;83:273–8.
- Leger RM, Arndt PA, Garratty G. Serological studies of piperacillin antibodies. Transfusion 2008;48:2429–34.
- Leger RM, Garratty G. Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors. Transfusion 2011;51:1740–4.
- Arndt PA, Leger RM, Garratty G. IgM agglutinins to meropenem, a beta-lactam antibiotic, are found in plasma of healthy blood donors and random patients (abstract). Transfusion 2012;52(Suppl):26A.
- Mayer B, Yürek S, Salama A. Piperacillin-induced immune hemolysis: new cases and a concise review of the literature. Transfusion 2010;50:1135–8.
- Arndt PA, Leger RM, Garratty G. Serological characteristics of anti-piperacillin in seventeen patients with drug-induced immune hemolytic anemia (abstract). Transfusion 2010;50(Suppl):37A.
- Johnson ST. Warm autoantibody or drug dependent antibody? That is the question! Immunohematology 2007;23:161–4.
DOI: https://doi.org/10.21307/immunohematology-2019-098 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 44 - 54
Published on: Nov 6, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2019 P.A. Arndt, published by American National Red Cross
This work is licensed under the Creative Commons License.